TD SYNNEX CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that TD SYNNEX CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Nov 30, 2018 | $20.05B | Jan 28, 2019 |
| FY2018 | Nov 30, 2017 | $17.05B | Jan 28, 2019 |
| FY2018 | Nov 30, 2016 | $14.06B | Jan 28, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $62.51B | Jan 27, 2026 |
| FY2025 | Nov 30, 2024 | $58.45B | Jan 27, 2026 |
| FY2025 | Nov 30, 2023 | $57.56B | Jan 27, 2026 |
| FY2024 | Nov 30, 2022 | $62.34B | Jan 24, 2025 |
| FY2023 | Nov 30, 2021 | $31.61B | Jan 26, 2024 |
| FY2022 | Nov 30, 2020 | $19.98B | Jan 24, 2023 |
| FY2021 | Nov 30, 2019 | $19.07B | Jan 28, 2022 |
| FY2020 | Nov 30, 2018 | $19.77B | Jan 28, 2021 |
| FY2019 | Nov 30, 2017 | $16.77B | Jan 29, 2020 |
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Nov 30, 2017 | $17.05B | Jan 29, 2018 |
| FY2017 | Nov 30, 2016 | $14.06B | Jan 29, 2018 |
| FY2017 | Nov 30, 2015 | $13.34B | Jan 29, 2018 |
| FY2016 | Nov 30, 2014 | $13.84B | Jan 26, 2017 |
| FY2015 | Nov 30, 2013 | $10.85B | Jan 28, 2016 |
| FY2014 | Nov 30, 2012 | $10.29B | Jan 29, 2015 |
| FY2013 | Nov 30, 2011 | $10.41B | Jan 27, 2014 |
| FY2012 | Nov 30, 2010 | $8.61B | Jan 28, 2013 |
| FY2011 | Nov 30, 2009 | $7.72B | Jan 27, 2012 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $4.37B | Jan 27, 2026 |
| FY2025 | Nov 30, 2024 | $3.98B | Jan 27, 2026 |
| FY2025 | Nov 30, 2023 | $3.96B | Jan 27, 2026 |
| FY2024 | Nov 30, 2022 | $3.90B | Jan 24, 2025 |
| FY2023 | Nov 30, 2021 | $1.89B | Jan 26, 2024 |
| FY2022 | Nov 30, 2020 | $1.19B | Jan 24, 2023 |
| FY2021 | Nov 30, 2019 | $1.16B | Jan 28, 2022 |
| FY2020 | Nov 30, 2018 | $1.93B | Jan 28, 2021 |
| FY2019 | Nov 30, 2017 | $1.55B | Jan 29, 2020 |
| FY2018 | Nov 30, 2016 | $1.28B | Jan 28, 2019 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $827.66M | Jan 27, 2026 |
| FY2025 | Nov 30, 2024 | $689.09M | Jan 27, 2026 |
| FY2025 | Nov 30, 2023 | $626.91M | Jan 27, 2026 |
| FY2024 | Nov 30, 2022 | $651.31M | Jan 24, 2025 |
| FY2023 | Nov 30, 2021 | $395.07M | Jan 26, 2024 |
| FY2022 | Nov 30, 2020 | $529.16M | Jan 24, 2023 |
| FY2021 | Nov 30, 2019 | $500.71M | Jan 28, 2022 |
| FY2020 | Nov 30, 2018 | $299.98M | Jan 28, 2021 |
| FY2019 | Nov 30, 2017 | $300.24M | Jan 29, 2020 |
| FY2018 | Nov 30, 2016 | $234.95M | Jan 28, 2019 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $1.41B | Jan 27, 2026 |
| FY2025 | Nov 30, 2024 | $1.19B | Jan 27, 2026 |
| FY2025 | Nov 30, 2023 | $1.08B | Jan 27, 2026 |
| FY2024 | Nov 30, 2022 | $1.05B | Jan 24, 2025 |
| FY2023 | Nov 30, 2021 | $623.22M | Jan 26, 2024 |
| FY2022 | Nov 30, 2020 | $521.34M | Jan 24, 2023 |
| FY2021 | Nov 30, 2019 | $519.43M | Jan 28, 2022 |
| FY2020 | Nov 30, 2018 | $550.24M | Jan 28, 2021 |
| FY2019 | Nov 30, 2017 | $507.34M | Jan 29, 2020 |
| FY2018 | Nov 30, 2016 | $379.60M | Jan 28, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $2.95B | Jan 27, 2026 |
| FY2025 | Nov 30, 2024 | $2.72B | Jan 27, 2026 |
| FY2025 | Nov 30, 2023 | $2.67B | Jan 27, 2026 |
| FY2024 | Nov 30, 2022 | $2.63B | Jan 24, 2025 |
| FY2023 | Nov 30, 2021 | $1.15B | Jan 26, 2024 |
| FY2022 | Nov 30, 2020 | $665.10M | Jan 24, 2023 |
| FY2021 | Nov 30, 2019 | $636.85M | Jan 28, 2022 |
| FY2020 | Nov 30, 2018 | $1.38B | Jan 28, 2021 |
| FY2019 | Nov 30, 2017 | $1.04B | Jan 29, 2020 |
| FY2018 | Nov 30, 2016 | $903.37M | Jan 28, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $1.53B | Jan 27, 2026 |
| FY2025 | Nov 30, 2024 | $1.22B | Jan 27, 2026 |
| FY2025 | Nov 30, 2023 | $1.41B | Jan 27, 2026 |
| FY2024 | Nov 30, 2022 | ($49.60M) | Jan 24, 2025 |
| FY2023 | Nov 30, 2021 | $809.79M | Jan 26, 2024 |
| FY2022 | Nov 30, 2020 | $1.83B | Jan 24, 2023 |
| FY2021 | Nov 30, 2019 | $549.92M | Jan 28, 2022 |
| FY2020 | Nov 30, 2018 | $100.71M | Jan 28, 2021 |
| FY2019 | Nov 30, 2017 | $176.76M | Jan 29, 2020 |
| FY2018 | Nov 30, 2016 | $324.70M | Jan 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Nov 30, 2022 | $65.29M | Jan 24, 2023 |
| FY2022 | Nov 30, 2021 | $39.69M | Jan 24, 2023 |
| FY2022 | Nov 30, 2020 | $26.63M | Jan 24, 2023 |
| FY2021 | Nov 30, 2019 | $137.42M | Jan 28, 2022 |
| FY2020 | Nov 30, 2018 | $125.31M | Jan 28, 2021 |
| FY2019 | Nov 30, 2017 | $97.55M | Jan 29, 2020 |
| FY2018 | Nov 30, 2016 | $123.23M | Jan 28, 2019 |
| FY2017 | Nov 30, 2015 | $100.11M | Jan 29, 2018 |
| FY2016 | Nov 30, 2014 | $57.38M | Jan 26, 2017 |
| FY2015 | Nov 30, 2013 | $28.97M | Jan 28, 2016 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $34.25B | Jan 27, 2026 |
| FY2025 | Nov 30, 2024 | $30.27B | Jan 27, 2026 |
| FY2024 | Nov 30, 2023 | $29.41B | Jan 24, 2025 |
| FY2023 | Nov 30, 2022 | $29.73B | Jan 26, 2024 |
| FY2022 | Nov 30, 2021 | $27.67B | Jan 24, 2023 |
| FY2021 | Nov 30, 2020 | $13.47B | Jan 28, 2022 |
| FY2020 | Nov 30, 2019 | $11.70B | Jan 28, 2021 |
| FY2020 | Nov 30, 2018 | $11.54B | Jan 28, 2021 |
| FY2019 | Nov 30, 2017 | $7.76B | Jan 29, 2020 |
| FY2018 | Nov 30, 2016 | $5.22B | Jan 28, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $25.80B | Jan 27, 2026 |
| FY2025 | Nov 30, 2024 | $22.24B | Jan 27, 2026 |
| FY2024 | Nov 30, 2023 | $21.23B | Jan 24, 2025 |
| FY2023 | Nov 30, 2022 | $21.71B | Jan 26, 2024 |
| FY2022 | Nov 30, 2021 | $19.76B | Jan 24, 2023 |
| FY2021 | Nov 30, 2020 | $9.13B | Jan 28, 2022 |
| FY2020 | Nov 30, 2019 | $7.91B | Jan 28, 2021 |
| FY2019 | Nov 30, 2018 | $8.11B | Jan 29, 2020 |
| FY2018 | Nov 30, 2017 | $5.41B | Jan 28, 2019 |
| FY2017 | Nov 30, 2016 | $3.24B | Jan 29, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $8.45B | Jan 27, 2026 |
| FY2025 | Nov 30, 2024 | $8.04B | Jan 27, 2026 |
| FY2025 | Nov 30, 2023 | $8.18B | Jan 27, 2026 |
| FY2025 | Nov 30, 2022 | $8.03B | Jan 27, 2026 |
| FY2024 | Nov 30, 2021 | $7.91B | Jan 24, 2025 |
| FY2023 | Nov 30, 2020 | $4.34B | Jan 26, 2024 |
| FY2022 | Nov 30, 2019 | $3.79B | Jan 24, 2023 |
| FY2021 | Nov 30, 2018 | $3.44B | Jan 28, 2022 |
| FY2020 | Nov 30, 2017 | $2.29B | Jan 28, 2021 |
| FY2017 | Nov 30, 2016 | $1.98B | Jan 29, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $4.10B | Jan 27, 2026 |
| FY2025 | Nov 30, 2024 | $3.90B | Jan 27, 2026 |
| FY2024 | Nov 30, 2023 | $3.90B | Jan 24, 2025 |
| FY2023 | Nov 30, 2022 | $3.80B | Jan 26, 2024 |
| FY2022 | Nov 30, 2021 | $3.92B | Jan 24, 2023 |
| FY2021 | Nov 30, 2020 | $423.89M | Jan 28, 2022 |
| FY2020 | Nov 30, 2019 | $2.25B | Jan 28, 2021 |
| FY2020 | Nov 30, 2018 | $2.20B | Jan 28, 2021 |
| FY2019 | Nov 30, 2017 | $872.64M | Jan 29, 2020 |
| FY2018 | Nov 30, 2016 | $486.24M | Jan 28, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $3.44B | Jan 27, 2026 |
| FY2025 | Nov 30, 2024 | $2.76B | Jan 27, 2026 |
| FY2024 | Nov 30, 2023 | $2.20B | Jan 24, 2025 |
| FY2023 | Nov 30, 2022 | $1.71B | Jan 26, 2024 |
| FY2022 | Nov 30, 2021 | $1.17B | Jan 24, 2023 |
| FY2021 | Nov 30, 2020 | $3.13B | Jan 28, 2022 |
| FY2020 | Nov 30, 2019 | $2.62B | Jan 28, 2021 |
| FY2019 | Nov 30, 2018 | $2.20B | Jan 29, 2020 |
| FY2018 | Nov 30, 2017 | $1.95B | Jan 28, 2019 |
| FY2017 | Nov 30, 2016 | $1.70B | Jan 29, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | $2.44B | Jan 27, 2026 |
| FY2025 | Nov 30, 2024 | $1.06B | Jan 27, 2026 |
| FY2024 | Nov 30, 2023 | $1.03B | Jan 24, 2025 |
| FY2023 | Nov 30, 2022 | $522.60M | Jan 26, 2024 |
| FY2022 | Nov 30, 2021 | $993.97M | Jan 24, 2023 |
| FY2021 | Nov 30, 2020 | $1.41B | Jan 28, 2022 |
| FY2020 | Nov 30, 2019 | $225.53M | Jan 28, 2021 |
| FY2019 | Nov 30, 2018 | $454.69M | Jan 29, 2020 |
| FY2018 | Nov 30, 2017 | $550.69M | Jan 28, 2019 |
| FY2017 | Nov 30, 2016 | $380.72M | Jan 29, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2016 | Nov 30, 2016 | $966.97M | Jan 26, 2017 |
| FY2015 | Nov 30, 2015 | $730.89M | Jan 28, 2016 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 9 | Jan 27, 2026 |
| FY2025 | Nov 30, 2024 | 7 | Jan 27, 2026 |
| FY2025 | Nov 30, 2023 | 6 | Jan 27, 2026 |
| FY2024 | Nov 30, 2022 | 6 | Jan 24, 2025 |
| FY2023 | Nov 30, 2021 | 6 | Jan 26, 2024 |
| FY2022 | Nov 30, 2020 | 10 | Jan 24, 2023 |
| FY2021 | Nov 30, 2019 | 9 | Jan 28, 2022 |
| FY2020 | Nov 30, 2018 | 7 | Jan 28, 2021 |
| FY2019 | Nov 30, 2017 | 7 | Jan 29, 2020 |
| FY2018 | Nov 30, 2016 | 5 | Jan 28, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 9 | Jan 27, 2026 |
| FY2025 | Nov 30, 2024 | 7 | Jan 27, 2026 |
| FY2025 | Nov 30, 2023 | 6 | Jan 27, 2026 |
| FY2024 | Nov 30, 2022 | 6 | Jan 24, 2025 |
| FY2023 | Nov 30, 2021 | 6 | Jan 26, 2024 |
| FY2022 | Nov 30, 2020 | 10 | Jan 24, 2023 |
| FY2021 | Nov 30, 2019 | 9 | Jan 28, 2022 |
| FY2020 | Nov 30, 2018 | 7 | Jan 28, 2021 |
| FY2019 | Nov 30, 2017 | 7 | Jan 29, 2020 |
| FY2018 | Nov 30, 2016 | 5 | Jan 28, 2019 |